Stay updated on Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page
- Check2 days agoChange DetectedA new revision entry (v3.3.4) was added to the Record History, and a prior revision (v3.3.3) was removed, an administrative update to the site's version history; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedNew contacts/locations and study status entries were added to the study record history (version 14, dated 2025-12-23; also noted on 2025-12-05). The 2025-10-24 version was removed.SummaryDifference0.5%

- Check23 days agoChange DetectedAdded Revision: v3.3.3 to the history. Removed the HHS Vulnerability Disclosure and Revision: v3.3.2 from the page.SummaryDifference0.2%

- Check52 days agoChange DetectedAdded a new revision entry 'Revision: v3.3.2' and removed the previous 'Revision: v3.2.0' from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedThe general operating status notice at the top of the page has been removed. This change affects site-wide messaging rather than the study record details.SummaryDifference0.7%

- Check74 days agoChange DetectedOnly minor UI changes are visible (header/navigation and page chrome). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page.